famotidine and s 1743
famotidine has been researched along with s 1743 in 10 studies
Research
Studies (10)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ananthakrishnan, S; Braverman, LE; Levin, RM; Magnani, B; Pearce, EN | 1 |
| Antonioli, L; Blandizzi, C; Colucci, R; Del Tacca, M; Fornai, M; Ghisu, N; Tuccori, M | 1 |
| Antonioli, L; Awwad, O; Basolo, F; Blandizzi, C; Colucci, R; Fornai, M; Fulceri, F; Natale, G; Tuccori, M; Ugolini, C | 1 |
| Chan, FK; Lam, KF; Lau, YK; Ng, FH; Tunggal, P | 1 |
| Chan, K; Chu, WM; Keung, KK; Kng, C; Kwan, A; Lam, KF; Lau, YK; Li, A; Ng, FH; Tunggal, P; Wong, BC | 1 |
| Edwards, O; Hoffman, JM; Morton, KA; Wang, LM; Wu, Q; Yakish, ED | 1 |
| Chen, C; Huang, S; Lin, D; Luo, Y; Wu, Y; Yu, W | 1 |
| Hecht, S; Kuhl, A; Marshall, K; Odunayo, A; Price, J; Steiner, J; Tolbert, MK | 1 |
| Gould, EN; Lennon, EM; Steiner, JM; Szule, JA; Tolbert, MK; Wilson-Robles, H | 1 |
| Choi, YS; Hwang, JG; Kim, HS; Kim, HY; Kim, JW; Kim, YK; Lee, JH; Min, HJ; Park, MK; Seong, CH | 1 |
Trials
5 trial(s) available for famotidine and s 1743
| Article | Year |
|---|---|
The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption.
Topics: Adult; Anti-Ulcer Agents; Anticholesteremic Agents; Azetidines; Dose-Response Relationship, Drug; Esomeprazole; Ezetimibe; Famotidine; Female; Humans; Intestinal Absorption; Male; Random Allocation; Thyroxine; Triiodothyronine | 2008 |
Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trial.
Topics: Acute Coronary Syndrome; Anti-Ulcer Agents; Blood Platelets; Clopidogrel; Double-Blind Method; Esomeprazole; Famotidine; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Treatment Outcome | 2011 |
Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction.
Topics: Acute Coronary Syndrome; Aged; Anti-Ulcer Agents; Aspirin; Chi-Square Distribution; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Esomeprazole; Famotidine; Female; Fibrinolytic Agents; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intestinal Perforation; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Ticlopidine; Treatment Outcome | 2012 |
Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs.
Topics: Animals; Anti-Ulcer Agents; Cross-Over Studies; Dogs; Esomeprazole; Famotidine; Female; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Pantoprazole | 2020 |
Comparison of the acid suppression effects between low-dose esomeprazole and famotidine in healthy subjects.
Topics: Cross-Over Studies; Esomeprazole; Famotidine; Gastritis; Healthy Volunteers; Humans | 2023 |
Other Studies
5 other study(ies) available for famotidine and s 1743
| Article | Year |
|---|---|
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Caspase 3; Dinoprostone; Disease Models, Animal; Esomeprazole; Famotidine; Indomethacin; Male; Malondialdehyde; Melatonin; NF-kappa B; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Stomach Ulcer; Treatment Outcome; Wound Healing | 2009 |
Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Proliferation; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Esomeprazole; Famotidine; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Immunohistochemistry; Indomethacin; Ki-67 Antigen; Lansoprazole; Male; Malondialdehyde; Proliferating Cell Nuclear Antigen; Proton Pump Inhibitors; Rats; Rats, Wistar; Stomach Ulcer; Time Factors; Vascular Endothelial Growth Factor A; Wound Healing | 2011 |
Histamine Receptor 1 and 2 Antagonists Alter Biodistribution of Radioiodine.
Topics: Animals; Drug Interactions; Esomeprazole; Famotidine; Gastric Mucosa; Histamine Antagonists; Iodine Radioisotopes; Male; Organ Specificity; Promethazine; Proton Pump Inhibitors; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Histamine H1; Receptors, Histamine H2; Salivary Glands; Thyroid Gland; Tissue Distribution | 2015 |
The effect of esomeprazole vs famotidine on aspirin/clopidogrel dual therapy after percutaneous coronary intervention.
Topics: Aspirin; Blood Platelets; Clopidogrel; Drug Therapy, Combination; Esomeprazole; Famotidine; Humans; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine; Treatment Outcome | 2019 |
Esomeprazole induces structural changes and apoptosis and alters function of in vitro canine neoplastic mast cells.
Topics: Animals; Apoptosis; Dogs; Esomeprazole; Famotidine; Humans; Mast Cells; Mice; Prospective Studies; Proton Pump Inhibitors; Rats | 2023 |